WallStreetZenWallStreetZen

NASDAQ: INCY
Incyte Corp Stock Ownership - Who owns Incyte?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Incyte Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael James MorrisseyEVP Head of Tech. Operations2025-12-174,323$97.26
$420.45kSell
Michael James MorrisseyEVP Head of Tech. Operations2025-12-16833$97.42
$81.15kSell
Michael James MorrisseyEVP Head of Tech. Operations2025-12-1653,175$97.29
$5.17MSell
Patrick A. MayesEVP Chief Scientific Officer2025-12-11255$94.94
$24.21kSell
Patrick A. MayesEVP Chief Scientific Officer2025-12-105,553$95.58
$530.76kSell
Herve HoppenotDirector2025-12-082,843$96.70
$274.92kSell
Steven H. SteinEVP Chief Medical Officer2025-12-0220,105$102.51
$2.06MSell
Steven H. SteinEVP Chief Medical Officer2025-12-012,559$102.96
$263.47kSell
Steven H. SteinEVP Chief Medical Officer2025-12-0117,093$102.04
$1.74MSell
Michael James MorrisseyEVP Head of Tech. Operations2025-12-01326$102.04
$33.27kSell

1 of 11

INCY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INCY insiders and whales buy or sell their stock.

INCY Shareholders

What type of owners hold Incyte Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP15.66%30,743,663$3.16BInstitution
Vanguard Group Inc10.16%19,951,623$2.05BInstitution
Julian Baker10.11%19,851,744$2.04BInsider
Blackrock Inc9.11%17,894,297$1.84BInstitution
Dodge Cox7.10%13,932,416$1.43BInstitution
Baker Brothers Life Sciences LP6.34%12,445,783$1.28BInsider
Baker Brothers Life Sciences Capital GP LLC6.33%12,430,783$1.28BInsider
State Street Corp4.93%9,676,796$993.71MInstitution
Aqr Capital Management LLC4.04%7,923,511$813.67MInstitution
Baker Biotech Capital GP LLC2.50%4,911,003$504.31MInsider

1 of 3

INCY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INCY77.70%22.30%Net SellingNet Selling
GMAB96.17%0.00%
BNTX20.98%0.00%
UTHR86.71%13.29%Net SellingNet Selling
RPRX56.76%17.33%Net SellingNet Selling
View Top Biotech Stocks

Incyte Stock Ownership FAQ

Who owns Incyte?

Incyte (NASDAQ: INCY) is owned by 100.80% institutional shareholders, 28.94% Incyte insiders, and 0.00% retail investors. Julian Baker is the largest individual Incyte shareholder, owning 19.85M shares representing 10.11% of the company. Julian Baker's Incyte shares are currently valued at $2.04B.

If you're new to stock investing, here's how to buy Incyte stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.